{
Merck & Co

People

}
001122334455554433221100
001122334455554433221100

global hashimoto thyroiditis market projected to reach 12.6 billion by 2033

The global Hashimoto"s thyroiditis market is projected to grow from $8.3 billion in 2023 to $12.6 billion by 2033, with a CAGR of 4.26%. North America is expected to dominate the market, while Asia-Pacific will experience the fastest growth due to rising healthcare awareness and improved infrastructure. The tablet segment will hold the largest market share, driven by convenience and patient compliance.
Spherical Insights
United States Dollar Amgen Inc. Merck & Co., Inc. Novartis AG Sanofi Mylan N.V. Teva Pharmaceutical Industries Ltd. Bristol-Myers Squibb Company Takeda Pharmaceuticals Limited Company Bayer AG Pfizer Inc. Roche Holding AG AbbVie Inc. AstraZeneca PLC Eli Lilly and Company Glaxosmithkline plc ARG GBR FRA ITA KOR ZAF MEX USA BRA ESP SAU CAN QAT ARE JPN AUS DEU CHN RUS IND Pfizer Inc. AbbVie Inc. Mylan N.V. Inc. Merck & Co GlaxoSmithKline plc Show more
Healthcare, Market Report
04:38 19.11.2024

global small molecule injectable drugs market trends and regional insights 2021

The global small-molecule injectable drugs market reached $188.9 billion in 2021, with a projected growth rate of 8% CAGR, expected to hit $837.8 billion by 2030. North America leads the market with a 37% share, driven by increased R&D and product approvals, while Europe is anticipated to grow the fastest due to rising demand for minimally invasive procedures. Intravenous injections accounted for 30% of the market, highlighting their critical role in rapid drug administration.
Spherical Insights
United States Dollar Pfizer Inc. Novartis AG טבע תעשיות פרמצבטיות Ltd. Aurobindo Pharma Limited Merck & Co., Inc. FRA RUS GBR ITA ESP USA KOR SAU JPN MEX ARE ZAF BRA ARG CHN QAT AUS IND DEU CAN Merck & Co Teva Pharmaceutical Industries Ltd. Pfizer Inc. Novartis AG Inc. AstraZeneca Plc. Show more
Healthcare, Market Report
22:59 28.10.2024

former seagen ceo launches ottimo pharma to combat various cancers

David Epstein, the former CEO of Seagen Inc., has launched a new biotech company, Ottimo Pharma, focused on developing a drug that addresses multiple cancer vulnerabilities. This innovative approach includes targeting a protein associated with Merck & Co.'s successful treatment, Keytruda. The company emerged after four years of development in secrecy.
Bloomberg.com
Pfizer Inc. Seagen Inc. Merck & Co., Inc. USA David Epstein Merck & Co Show more
Healthcare, News Article
09:30 28.10.2024

global pharmaceutical and healthcare market projected to reach 1924 billion by 2032

Rising healthcare costs are straining patients, payers, and providers, limiting access to care and pressuring the pharmaceutical industry to maintain lower prices. The global pharmaceuticals and healthcare market is projected to grow from $1,245.88 billion in 2021 to $1,924.24 billion by 2032, driven by technological advances and demographic changes. However, regulatory barriers and increasing costs pose significant challenges to market growth.
businessresearchinsights.com
United States Dollar Hoffmann-La Roche AG Johnson & Johnson Novartis AG Merck & Co., Inc. AbbVie Inc. CAN FRA GBR USA ISR JPN DNK DEU Merck & Co Roche Johnson & Johnson AbbVie Novartis Show more
Healthcare, Market Report
09:00 07.10.2024
Trending
Subcategory
Industry Trends Corporate News Startups & Entrepreneurship Global Trade Developments Supply Chain Management Government Economic Policies Stock Market Updates Retail and Consumer Goods Industry Mergers & Acquisitions Global Financial Events Private Equity Deals Venture Capital Investments Funding Rounds & Investments Finance Mergers & Acquisitions Workplace Trends Emerging Startups Energy Sector Developments Financial Scams and Security Cryptocurrency & Blockchain Regulations Central Bank Actions
Countries:
USA IND CHN JPN ARE TWN SAU GBR IDN SGP KOR EGY MEX MYS AUS THA VNM CAN HKG NGA
Companies:
Apple Inc. NVIDIA Corporation Google Inc. Samsung Securities Co.,Ltd. Tesmec S.p.A. Toyota Motor Corp Taiwan Semiconductor Manufacturing Company Limited Microsoft Corporation Verizon Communications Inc. OpenAI ERC USD The Goldman Sachs Group, Inc. Dell Technologies Inc. International Monetary Fund FUND Coinbase Global, Inc. Visa Inc. Mastercard Inc NIO Inc. Kraken Energy Corp. JD.com, Inc. Meituan
Currencies:
United States Dollar Chinese Yuan Euro Indian Rupee British Pound Sterling Japanese Yen Australian Dollar Indonesian Rupiah New Zealand Dollar South Korean Won Offshore Chinese Yuan Vietnamese Đồng New Taiwan Dollar Singapore Dollar Egyptian Pound Nigerian Naira South African Rand United Arab Emirates Dirham Malaysian Ringgit Lebanese Pound
People:
Donald Trump Howard Lutnick Shigeru Ishiba Scott Bessent Tim Cook Jamieson Greer Abdulaziz bin Salman Al Saud Mohammad Al Tamimi Mohammad Altamimi Jensen Huang Sam Altman Xi Jinping Chris Wright Christopher Flinos Mohammed bin Salman Al Saud John Abraham Piyush Anchliya Swaminathan Aiyar Todd Blanche Justin Sun

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.